ArticleInternational urology and nephrology2025

Effects of combining zibotentan and dapagliflozins on chronic kidney disease: an innovative frontier.

Muhammad Abdul Rehman Gulzar et al.PubMed ↗Publisher ↗

No numbers read from the abstract.